Vaughn Embro-Pantalony
Fortune : 350 517 $ au 31/05/2026
Fortune : 350 517 $ au 31/05/2026
Vaughn C.
Embro-Pantalony is Chief Executive Officer & President at Stratpath Management Inc. since 2007.
Serving as Chairman at Soricimed Biopharma, Inc. since 2018.
Independent Director at Microbix Biosystems, Inc. since 2017.
Independent Director at BriaCell Therapeutics Corp.
since 2019.
Formerly Managing Director at StratPath Group.
CFO, Director-Finance & Administration at Zeneca Pharma, Inc. from 1995 to 1996.
Chief Financial Officer & VP-Finance at Novopharm Ltd. from 2003 to 2006.
CIO & Vice President-Information Technology at Bayer, Inc. from 1996 to 2003.
Vice President-Finance & Administration at Bayer HealthCare from 1996 to 1999.
General Manager-Nitrogen Products at Terra International (Canada), Inc. from 1993 to 1994.
Educated at the University of Windsor with an MBA and at Wilfrid Laurier University with an undergraduate degree.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/02/2026 | 1 841 704 ( 1,33% ) | 349 924 $ | 31/05/2026 | |
| 28/01/2026 | 163 ( 0% ) | 593 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Directeur/Membre du Conseil | 06/02/2007 |
| BRIACELL THERAPEUTICS CORP. | Directeur/Membre du Conseil | 18/03/2019 |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage drug development company dedicated to novel targeted treatments of cancer | Président | 04/09/2018 |
Stratpath Management Inc. | Directeur Général | 06/02/2007 |
| Sociétés | Poste | Fin |
|---|---|---|
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 01/04/2006 |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Directeur Technique/Scientifique/R&D | 01/04/2003 |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Directeur Administratif | 01/06/1999 |
Zeneca Pharma, Inc. | Directeur Financier/CFO | 01/08/1996 |
Terra International (Canada), Inc. | Corporate Officer/Principal | 01/01/1994 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Microbix Biosystems, Inc.
Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage drug development company dedicated to novel targeted treatments of cancer | Health Technology |
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Manufactures chemicals, healthcare, agricultural, and life science products | Process Industries |
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
StratPath Group | |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Terra International (Canada), Inc. | |
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
Zeneca Pharma, Inc. | |
Stratpath Management Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national